DB16448InvestigationalProtein Based Therapies
CD24Fc is a biological immunomodulator originally developed to address graft-versus-host disease in stem cell transplantation in leukemia patients.
- Mechanism
- Curator reviewed
CD24Fc is a biological immunomodulator originally developed to address graft-versus-host disease in stem cell transplantation in leukemia patients. It has protective abilities against inflammatory mediators and potential to reduce lung pathology associated with pneumonia. The specific mechanisms by which CD24Fc works is currently unknown.
- Also known as
- Human CD24 and human IgG Fc Fusion Protein
- Code names
- CD24Fc · CD24IGG1FC · MK-7110
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Efprezimod alfa, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account